CASTIGLIONE, VINCENZO
 Distribuzione geografica
Continente #
EU - Europa 225
NA - Nord America 135
AS - Asia 49
AF - Africa 14
SA - Sud America 1
Totale 424
Nazione #
IT - Italia 145
US - Stati Uniti d'America 133
SG - Singapore 33
SE - Svezia 21
AT - Austria 14
CI - Costa d'Avorio 9
CN - Cina 9
CZ - Repubblica Ceca 9
DE - Germania 8
FR - Francia 7
BG - Bulgaria 5
GB - Regno Unito 5
SN - Senegal 5
PL - Polonia 4
IE - Irlanda 3
IN - India 3
CA - Canada 2
NL - Olanda 2
TH - Thailandia 2
VN - Vietnam 2
AL - Albania 1
AR - Argentina 1
CH - Svizzera 1
Totale 424
Città #
Chandler 23
Pisa 23
Florence 17
New York 14
Vienna 14
Milan 13
Singapore 11
Abidjan 9
Brno 9
Rome 9
Ashburn 8
Cascina 8
Ogden 7
Fairfield 6
Livorno 6
Serra 6
Dakar 5
Sofia 5
Castellazzo Bormida 4
Kent 4
Lucca 4
Warsaw 4
Ann Arbor 3
Bremen 3
Caserta 3
Dublin 3
London 3
Medford 3
Princeton 3
Seattle 3
Tuckerton 3
Vicopisano 3
Voghera 3
Cambridge 2
Frankfurt am Main 2
Hyderabad 2
Lawrence 2
Marseille 2
Paris 2
Piombino 2
Redwood City 2
Siena 2
Torino 2
Wilmington 2
Abbadia San Salvatore 1
Amsterdam 1
Angri 1
Beijing 1
Bellingham 1
Bern 1
Boardman 1
Bollate 1
Cinisello Balsamo 1
Dearborn 1
Dong Ket 1
Genoa 1
Glasgow 1
Grosseto 1
Houston 1
Los Angeles 1
Montecatini Terme 1
Munich 1
Nanchang 1
Nice 1
Ottawa 1
Pune 1
Redmond 1
San Giuliano Terme 1
Saronno 1
Shanghai 1
Toronto 1
Woodbridge 1
Totale 292
Nome #
null 97
Cardiac magnetic resonance in patients with muscular dystrophies 56
Myocardial Infarction Following COVID-19 Vaccine Administration: Post Hoc, Ergo Propter Hoc? 50
Use of biomarkers to diagnose and manage cardiac amyloidosis 41
The Journey of Human Transthyretin: Synthesis, Structure Stability, and Catabolism 36
SAFETY OF NOVEL ORAL ANTICOAGULANTS COMPARED TO VITAMIN K ANTAGONISTS IN THE TREATMENT OF VENOUS THROMBOEMBOLISM: A SYSTEMATIC REVIEW AND META-ANALYSIS 31
RNA-targeting and gene editing therapies for transthyretin amyloidosis 30
Atrial amyloidosis: mechanisms and clinical manifestations 23
Transthyretin Stabilizers and Seeding Inhibitors as Therapies for Amyloid Transthyretin Cardiomyopathy 21
Wild-type transthyretin cardiac amyloidosis is not rare in elderly subjects: the CATCH screening study 19
Characterization of Phenotypic Variability in Becker Muscular Dystrophy for Clinical Practice and Towards Trial Readiness: A Two-Years Follow up Study 13
Prevalence and clinical outcomes of isolated or combined moderate to severe mitral and tricuspid regurgitation in patients with cardiac amyloidosis 9
Haemodynamic forces predicting remodelling and outcome in patients with heart failure treated with sacubitril/valsartan 8
Right ventricular to pulmonary artery coupling and outcome in patients with cardiac amyloidosis 6
Effects of sacubitril-valsartan on remodelling, fibrosis and mitochondria in a murine model of isoproterenol-induced left ventricular dysfunction 5
Biomarkers: monoclonal protein and indicators of cardiac damage. 3
Intact fibroblast growth factor 23 in heart failure with reduced and mildly reduced ejection fraction 2
Pathophysiology of Cardiac Amyloidosis 2
Totale 452
Categoria #
all - tutte 1.463
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.463


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202015 1 0 0 1 1 1 5 2 4 0 0 0
2020/202128 0 0 0 6 3 4 6 3 2 0 0 4
2021/202235 0 1 0 5 4 4 0 4 3 2 3 9
2022/202398 4 11 8 5 11 10 0 8 28 0 13 0
2023/2024196 6 7 12 21 13 42 12 2 1 6 42 32
2024/202535 35 0 0 0 0 0 0 0 0 0 0 0
Totale 452